(Q28188525)

2

0 references

G A Hitman

3

0 references

C P Price

4

0 references

P G Mills

5

0 references

K Ranjadayalan

6

0 references

J Cooper

7

0 references

H Clark

8

0 references

A D Timmis

Journal of the American College of Cardiology

9

0 references

language of work or name

English

0 references

publication date

September 2001

0 references

published in

0 references

volume

38

0 references

issue

3

0 references

page(s)

724-8

0 references

cites work

A classification of unstable angina revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Progress in myocardial damage detection: new biochemical markers for clinicians

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Insights into the pathophysiology of unstable coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Suppressive effect of captopril on platelet aggregation in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Unstable angina. A classification

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Relationship between the response to the angiotensin converting enzyme inhibitor imidapril and the angiotensin converting enzyme genotype

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Plasma Activity and Insertion/Deletion Polymorphism of Angiotensin I–Converting Enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Clinical characteristics determining the mode of presentation in patients with acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Influence of previous aspirin treatment and smoking on the electrocardiographic manifestations of injury in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Determinants of collateral filling observed during sudden controlled coronary artery occlusion in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021

Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901426-7

7 January 2021